Tano Capital
-
Franchise India Bureau Sep 29 2017 - 1 min readPharmaceutical ingredients manufacturer Shilpa Medicare Ltd has received approval from its board to acquire the remaining stake in Hyderabad-based Nu Therapeutics Pvt Ltd for Rs3.21 crore, as per a stock market disclosure.Shilpa Medicare already owns 67.94 per cent stake in Nu Therapeutics. Following the approval from its board for the acquisition of remaining 32.06 per ...